Anhedonia modulates benzodiazepine and opioid demand among persons in treatment for opioid use disorder

Anhedonia modulates benzodiazepine and opioid demand among persons in treatment for opioid use disorder

BackgroundBenzodiazepine (BZD) misuse is a significant public health problem, particularly in conjunction with opioid use, due to increased risks of overdose and death. One putative mechanism underlying BZD misuse is affective dysregulation, via exaggerated negative affect (e.g., anxiety, depression...

Full description

Bibliographic Details
Main Authors:	Mark K. Greenwald, Tabitha E. H. Moses, Leslie H. Lundahl, Timothy A. Roehrs
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-01-01
Series:	Frontiers in Psychiatry
Subjects:	benzodiazepine demand anhedonia affective dysregulation opioid use disorder
Online Access:	https://www.frontiersin.org/articles/10.3389/fpsyt.2023.1103739/full

Similar Items

The effect of opioid analgesics, benzodiazepines, gabapentinoids, and opioid agonist treatment on mortality risk among opioid-dependent people.
by: Chrianna Bharat, et al.
Published: (2022-08-01)

Co-prescription of opioids with benzodiazepine and other co-medications among opioid users: differential in opioid doses
by: Zin CS, et al.
Published: (2017-01-01)

Deprescribing Strategies for Opioids and Benzodiazepines with Emphasis on Concurrent Use: A Scoping Review
by: Yanning Wang, et al.
Published: (2023-02-01)

Adverse outcomes associated with concurrent gabapentin, opioid, and benzodiazepine utilization: A nested case-control study
by: Abisola Olopoenia, et al.
Published: (2022-09-01)

Screening and Confirmation of Opioids, Amphetamines and Benzodiazepines in Wastewater by High-Resolution Mass Spectrometry
by: YUAN Shuai, et al.
Published: (2021-11-01)

Opioid and/or Psychotropic Use Increases Intraprocedural Sedation Drug Requirements
by: Sreeja Sanampudi, et al.
Published: (2022-04-01)

How do contraindications to non-opioid analgesics and opioids affect the likelihood that patients with back pain diagnoses in the primary care setting receive an opioid prescription? An observational cross-sectional study
by: Michelle S. Keller, et al.
Published: (2021-02-01)

Preliminary Investigation of Pharmacist-Delivered, Direct-to-Provider Interventions to Reduce Co-Prescribing of Opioids and Benzodiazepines among a Medicare Population
by: Jennifer M. Bingham, et al.
Published: (2020-02-01)

Assessment of anhedonia in psychological trauma: psychometric and neuroimaging perspectives
by: Paul A. Frewen, et al.
Published: (2012-01-01)

A descriptive analysis of concomitant opioid and benzodiazepine medication use and associated adverse drug events in United States adults between 2009 and 2018
by: Kathryn K. Marwitz, et al.
Published: (2022-03-01)

Evaluation of concurrent benzodiazepine and opioid prescribing patterns with a focus on acute muscle spasms indication at hospital discharge
by: Danielle Firkus, et al.
Published: (2022-12-01)

Assessment of anhedonia in psychological trauma: development of the Hedonic Deficit and Interference Scale
by: Paul A. Frewen, et al.
Published: (2012-01-01)

The kappa opioid receptor: from addiction to depression, and back
by: Laurence eLalanne, et al.
Published: (2014-12-01)

The Developmental Origins of Opioid Use Disorder and Its Comorbidities
by: Sophia C. Levis, et al.
Published: (2021-02-01)

Recommendations for benzodiazepine use and detoxification for patients in medication-assisted (substitution) treatment programmes for opioid addiction in the Republic of Slovenia
by: Andrej Kastelic, et al.
Published: (2013-11-01)

Dispensations of benzodiazepines, z-hypnotics, and gabapentinoids to patients receiving opioid agonist therapy; a prospective cohort study in Norway from 2013 to 2017
by: Jørn Henrik Vold, et al.
Published: (2020-04-01)

Virtual Reality Reward Training for Anhedonia: A Pilot Study
by: Kelly Chen, et al.
Published: (2021-01-01)

Benzodiazepine Use in Opioid Maintenance Treatment Programme: Risks and Clinical Outcomes
by: Catarina Oliveira, et al.
Published: (2021-03-01)

Co-prescribing of opioids and benzodiazepines/Z-drugs associated with all-cause mortality—A population-based longitudinal study in primary care with weak opioids most commonly prescribed
by: Kristjan Linnet, et al.
Published: (2022-09-01)

Concurrent opioid and alcohol withdrawal management
by: Michelle Colvard, PharmD, BCPP
Published: (2023-12-01)

Social and physical anhedonia in relation to grandiose and vulnerable narcissism
by: Magdalena Linke-Jankowska, et al.
Published: (2021-03-01)

Association of Cognitive Impairment With Anhedonia in Patients With Schizophrenia
by: Lingfang Yu, et al.
Published: (2021-12-01)

Long-term use of benzodiazepines in chronic insomnia: a European perspective
by: Michael Soyka, et al.
Published: (2023-08-01)

Benzodiazepine use in patients with chronic pain in an interdisciplinary pain rehabilitation program
by: Cunningham JL, et al.
Published: (2017-02-01)

A novel construct of anhedonia revealed in a Chinese sample via the Revised Physical and Social Anhedonia Scales
by: Qiongqiong Wu, et al.
Published: (2020-11-01)

Anhedonia. Depressive versus negative symptom
by: T. Reynolds De Sousa, et al.
Published: (2022-06-01)

Opioid prescribing in general practice: an Australian cross-sectional survey
by: Sharon Reid, et al.
Published: (2022-07-01)

Anhedonia as a basic syndrome and a target for treatment for depressive disorder
by: G. E. Mazo, et al.
Published: (2019-10-01)

Training medical students in opioid overdose prevention and response: Comparison of In-Person versus online formats
by: Tabitha E. H. Moses, et al.
Published: (2021-01-01)

Tapering (deprescribing) of benzodiazepine tranquilizers
by: D. A. Sychev, et al.
Published: (2019-03-01)

Preliminary Evidence for Anhedonia as a Marker of Sexual Trauma in Female Adolescents
by: Sonmez AI, et al.
Published: (2021-06-01)

Healthcare costs and utilization associated with high-risk prescription opioid use: a retrospective cohort study
by: Hsien-Yen Chang, et al.
Published: (2018-05-01)

Body and Social Anhedonia of Depression: A Bifactor Model Analysis
by: Bo Feng, et al.
Published: (2020-04-01)

Factors associated with the prescribing of high-dose opioids in primary care: a systematic review and meta-analysis
by: Georgia C. Richards, et al.
Published: (2020-03-01)

Anhedonia in Acne Vulgaris: A Cross-Sectional Study of 104 Consecutive Acne Patients
by: Szepietowska M, et al.
Published: (2024-02-01)

Prescription drugs with potential for misuse in Irish prisons: analysis of national prison prescribing trends, by gender and history of opioid use disorder, 2012 to 2020
by: Louise Durand, et al.
Published: (2023-10-01)

Multiple Sclerosis and the Endogenous Opioid System
by: Zoë Dworsky-Fried, et al.
Published: (2021-09-01)

Polysubstance mortality trends in White and Black Americans during the opioid epidemic, 1999–2018
by: Marwa Rawy, et al.
Published: (2024-01-01)

Anhedonia in endometriosis: An unexplored symptom
by: Aida Mallorquí, et al.
Published: (2022-09-01)

Chemosensory Anhedonia in Patients With Schizophrenia and Individuals With Schizotypy: A Questionnaire Study
by: Zi-lin Li, et al.
Published: (2020-06-01)